
UnitedHealth Group raises 2026 EPS guidance, signaling strong growth and undervalued shares
UnitedHealth Group has raised its 2026 adjusted diluted EPS guidance to $19.50–$20.00, driven by strong margin control, AI efficiencies, and growth in its Optum segment. The company maintains a solid balance sheet with an A+ credit rating and offers ...



